Evidence map›Paper›PMID 37601382›Full record

ArticleFrontiers in microbiology2023

Enhancing plant defense using rhizobacteria in processing tomatoes: a bioprospecting approach to overcoming Early Blight and

Gabriele Bellotti, Maria Chiara Guerrieri, Paola Giorni, Giulia Bulla, Andrea Fiorini, Terenzio Bertuzzi, Maria Elena Antinori, Edoardo Puglisi

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Biocontrol of Fungal Pathogens of Winter Oilseed Rape (Molecules (Basel, Switzerland) · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Distribution ofFrontiers in fungal biology · 2025
    Article
  7. Article
  8. Biology, ecology, and epidemiology ofFrontiers in plant science · 2024
    Review
  9. Phosphate solubilizingFrontiers in microbiology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Gabriele BellottiDepartment for Sustainable Food Process, Università Cattolica del Sacro Cuore, Piacenza, Italy.
Maria Chiara GuerrieriDepartment for Sustainable Food Process, Università Cattolica del Sacro Cuore, Piacenza, Italy.
Paola GiorniDepartment of Sustainable Crop Production, Università Cattolica del Sacro Cuore, Piacenza, Italy.
Giulia BullaDepartment of Sustainable Crop Production, Università Cattolica del Sacro Cuore, Piacenza, Italy.
Andrea FioriniDepartment of Sustainable Crop Production, Università Cattolica del Sacro Cuore, Piacenza, Italy.
Terenzio BertuzziDepartment of Animal Science, Food and Nutrition, Università Cattolica del Sacro Cuore, Piacenza, Italy.
Maria Elena AntinoriDepartment for Sustainable Food Process, Università Cattolica del Sacro Cuore, Piacenza, Italy.
Edoardo PuglisiDepartment for Sustainable Food Process, Università Cattolica del Sacro Cuore, Piacenza, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Plant growth-promoting rhizobacteria (PGPR) with antagonistic activity toward plant pathogenic fungi are valuable candidates for the development of novel plant protection products based on biocontrol activity. The very first step in the formulation of such products is to screen the potential effectiveness of the selected microorganism(s). In this study, non-pathogenic rhizobacteria were isolated from the rhizosphere of tomato plants and evaluated for their biocontrol activity against three species of mycotoxin-producing

Indexed as

AlternariaBacillusbacterial-fungal interactionsbiocontrol agentsmicrobial-based biopesticidesmycotoxinsPGPRtomato

Identifiers

PMID37601382
PMCPMC10436473

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.